Non-Alcoholic Fatty Liver Disease Latest Advances

Weekend warrior physical activity pattern and risk of all-cause and cardiovascular mortality among US adults with metabolic dysfunction-associated steatotic liver disease: A prospective cohort study of NHANES 2007-2018.

Journal: Science progress

Published: April 15, 2026

New approach methodologies to model liver fibrosis in metabolic dysfunction-associated steatohepatitis.

Journal: BMB reports

Published: April 15, 2026

Assessment of exonic polymorphism of IDH2, KRAS1, TP53, and BRAF2 using PCR-RFLP in hepatocellular carcinoma: a case-control study from Arunachal Pradesh and Sikkim.

Journal: Personalized medicine

Published: April 14, 2026

UPLC-Q-TOF/MS-Based Metabolomics and 16S rRNA Profiling Reveal that Corosolic Acid Ameliorates High-Fat Diet-Induced MASLD by Modulating the Gut-Liver Axis to Inhibit the cGAS-STING Pathway.

Journal: Journal of agricultural and food chemistry

Published: April 14, 2026

A rare vascular sequela: segmental hepatic steatosis secondary to postoperative portal vein stenosis after liver transplantation.

Journal: RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin

Published: April 14, 2026

Correction to: Diacerein improves liver fibrosis, steatosis, and atherosclerosis in ApoE knockout mice.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: April 13, 2026

Endocrinology: What You May Have Missed in 2025.

Journal: Annals of internal medicine

Published: April 13, 2026

Plasma proteome profiling identifies XPNPEP3 as a novel biomarker associated with metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus.

Journal: Annals of medicine

Published: April 13, 2026

Therapeutic Efficacy, Biomarker Signatures and Translatability of Semaglutide in the Liver Biopsy-Confirmed GAN DIO-MASH Mouse Model.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: April 13, 2026

Gastroenterology/Hepatology: What You May Have Missed in 2025.

Journal: Annals of internal medicine

Published: April 13, 2026

Underlying MASLD-induced gut microbiome dysbiosis and intestinal inflammation are key to poor outcomes in vibriosis infections in a preclinical model.

Journal: Gut microbes

Published: April 13, 2026

Coffee Berry Pulp Extract Improves Hepatic Lipid Metabolism and Reduces Triglyceride Levels in High-Fat, High-Fructose Diet-Fed Mice.

Journal: Journal of medicinal food

Published: April 10, 2026

Non-Alcoholic Fatty Liver Disease Latest Advances

Find the Latest Research About Non-Alcoholic Fatty Liver Disease

Weekend warrior physical activity pattern and risk of all-cause and cardiovascular mortality among US adults with metabolic dysfunction-associated steatotic liver disease: A prospective cohort study of NHANES 2007-2018.

Weekend warrior physical activity pattern and risk of all-cause and cardiovascular mortality among US adults with metabolic dysfunction-associated steatotic liver disease: A prospective cohort study of NHANES 2007-2018.

New approach methodologies to model liver fibrosis in metabolic dysfunction-associated steatohepatitis.

New approach methodologies to model liver fibrosis in metabolic dysfunction-associated steatohepatitis.

Assessment of exonic polymorphism of IDH2, KRAS1, TP53, and BRAF2 using PCR-RFLP in hepatocellular carcinoma: a case-control study from Arunachal Pradesh and Sikkim.

Assessment of exonic polymorphism of IDH2, KRAS1, TP53, and BRAF2 using PCR-RFLP in hepatocellular carcinoma: a case-control study from Arunachal Pradesh and Sikkim.

UPLC-Q-TOF/MS-Based Metabolomics and 16S rRNA Profiling Reveal that Corosolic Acid Ameliorates High-Fat Diet-Induced MASLD by Modulating the Gut-Liver Axis to Inhibit the cGAS-STING Pathway.

UPLC-Q-TOF/MS-Based Metabolomics and 16S rRNA Profiling Reveal that Corosolic Acid Ameliorates High-Fat Diet-Induced MASLD by Modulating the Gut-Liver Axis to Inhibit the cGAS-STING Pathway.

A rare vascular sequela: segmental hepatic steatosis secondary to postoperative portal vein stenosis after liver transplantation.

A rare vascular sequela: segmental hepatic steatosis secondary to postoperative portal vein stenosis after liver transplantation.

Correction to: Diacerein improves liver fibrosis, steatosis, and atherosclerosis in ApoE knockout mice.

Correction to: Diacerein improves liver fibrosis, steatosis, and atherosclerosis in ApoE knockout mice.

Endocrinology: What You May Have Missed in 2025.

Endocrinology: What You May Have Missed in 2025.

Plasma proteome profiling identifies XPNPEP3 as a novel biomarker associated with metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus.

Plasma proteome profiling identifies XPNPEP3 as a novel biomarker associated with metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus.

Therapeutic Efficacy, Biomarker Signatures and Translatability of Semaglutide in the Liver Biopsy-Confirmed GAN DIO-MASH Mouse Model.

Therapeutic Efficacy, Biomarker Signatures and Translatability of Semaglutide in the Liver Biopsy-Confirmed GAN DIO-MASH Mouse Model.

Gastroenterology/Hepatology: What You May Have Missed in 2025.

Gastroenterology/Hepatology: What You May Have Missed in 2025.

Underlying MASLD-induced gut microbiome dysbiosis and intestinal inflammation are key to poor outcomes in vibriosis infections in a preclinical model.

Underlying MASLD-induced gut microbiome dysbiosis and intestinal inflammation are key to poor outcomes in vibriosis infections in a preclinical model.

Coffee Berry Pulp Extract Improves Hepatic Lipid Metabolism and Reduces Triglyceride Levels in High-Fat, High-Fructose Diet-Fed Mice.

Coffee Berry Pulp Extract Improves Hepatic Lipid Metabolism and Reduces Triglyceride Levels in High-Fat, High-Fructose Diet-Fed Mice.